This page is part of the FHIR Specification (v0.4.0: DSTU 2 Draft). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions
Drug-drug interaction between prescription and medication statement (id = "ddi")
<Contraindication xmlns="http://hl7.org/fhir"> <id value="ddi"/> <text> <status value="generated"/> <div xmlns="http://www.w3.org/1999/xhtml"><!-- Snipped for brevity --></div> </text> <category> <coding> <system value="http://hl7.org/fhir/v3/ActCode"/> <code value="DRG"/> <display value="Drug Interaction Alert"/> </coding> </category> <severity value="H"/> <implicated> <reference value="MedicationStatement/tylenol"/> <display value="500 mg Acetaminophen tablet 1/day, PRN since 2010"/> </implicated> <implicated> <reference value="MedicationPrescription/warfarin"/> <display value="Warfarin 1 MG TAB prescribed Jan. 5, 2014"/> </implicated> <detail value="Risk of internal bleeding. Those who take acetaminophen along with the widely used blood-thinning drug warfarin may face the risk of serious internal bleeding. People on warfarin who take acetaminophen for at least seven days in a row should be closely watched for bleeding."/> <date value="2014-01-05"/> <author> <reference value="Device/dsp"/> </author> <mitigation> <action> <coding> <system value="http://hl7.org/fhir/v3/ActCode"/> <code value="30"/> <display value="Stopped Concurrent Therapy"/> </coding> <text value="Asked patient to discontinue regular use of Tylenol and to consult with clinician if they need to resume to allow appropriate INR monitoring"/> </action> <date value="2014-01-05"/> <author> <reference value="Practitioner/example"/> <display value="Dr. Adam Careful"/> </author> </mitigation> </Contraindication>
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.